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Cutaneous xenobiotic metabolizing enzymes including 
aryl hydrocarbon hydroxylase (AHH), 7-ethoxycou-
marin 0-deethylase (ECD), epoxide hydrolase (EH) and 
glutathione S-transferase (GST) activities were exam-
ined in SKH hairless mice chronically irradiated with 
UVB to induce squamous cell carcinoma (SCC). Enzyme 
activities in irradiated tumor-bearing skin were com-
pared to those present in the skin of nonirradiated con-
trol animals as well as in unirradiated non-tumor bear-
ing skin sites of the SCC-bearing mice. The inducibility 
of skin AHH and ECD in each set of animals was assessed 
following a single topical application of coal tar (1 ml/ 
100 g). Enzyme-mediated binding of [aH]benzo(a)pyrene 
(BP) and its metabolite 7 /1,8a-dihydroxy-9a, 1 Oa-epoxy-
7 ,8,9 , 10-tetrahydrobenzo(a)pyrene (BPDE-I) to epider-
mal DNA was also evaluated. Basal AHH and ECD ac-
tivities in microsomes from UVB-irradiated SCC-bear-
ing dorsal skin were 4.6- and 4 .8-fold lower than those 
in dorsal skin of non irradiated control animals. Enzyme 
activities in non-tumor bearing ventral skin from the 
UVB-irradiated SCC-bearing mice also were 2.2 to 2.8-
fold lower as compared to activities in the nonirradiated 
control animals. The reduction in AHH activity paral-
leled the levels of enzyme-mediated binding of radiola-
beled BP metabolites and of BPDE-I to epidermal DNA. 
GST activity was found to be increased (173 %) in non-
tumor bearing ventral skin of UVB-irradiated mice 
whereas no difference in activity between SCC-bearing 
dorsal skin and dorsal skin of control animals could be 
detected. EH activity was unchanged in each group of 
animals. Treatment with topically applied coal tar re-
s ulted in higher inducibility of AHH and ECD in both 
sec-bearing (13-fold) as well as in non-tumor skin sites 
(6-fold) of UVB-irradiated mice than in skin of control 
animals (3-fold) . Coal tar application also increased the 
covalent binding of ['lH]BP and of the metabolite BPDE-
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Abbreviations: 
AHH: aryl hydroca rbon hydroxylase 
BP: benzo(a)pyrene 
BPDE- I: 7 {3,8a-dihydroxy-9a, lOa-epoxy- 7 ,8,9, 10-tetra hydro-
benzo(a)pyrene 
BP-4 ,5 -oxicle: benzo(a)pyrene 4,5-oxicle 
CD NB: 1-c h I oro-2,4 -din it robenzene 
ECD: 7-elhoxycoumarin 0-deethylase 
E H: epox icle hydrolase 
ELISA: enzyme- lin ked immunosorbent assay 
GST: glu lathione S- transferase 
NAD H: nicotinamide aden ine dinucleotide reduced 
NADP H: nicotinamide adenin e dinucleotide phosphate reduced 
3-0I-1 BP: 3-hyclroxybenzo(a)pyrene 
PAH: polycyc lic a romatic hydrocarbon 
SCC: squamous ce ll carcinoma 
I to skin DNA. This was greater in SCC-bearing dorsal 
skin (119-129%) than in nonirradiated skin of control 
animals (48-62%). Our studies suggest that the metab-
olism of BP by cutaneous cytochrome P-450 dependent 
monooxygenases is impaired in skin of mice irradiated 
chronically with UVB. The higher inducibility of these 
monooxygenases by topically applied coal tar and the 
enhancement of the associated enzyme-mediated cova-
lent binding of BP metabolites and BPDE-I to epidermal 
DNA indicate that repetitive exposure of mammalian 
skin to UVB radiation can profoundly alter the activity 
and the inducibility of drug and carcinogen metabolizing 
enzymes. These studies also illustrate the complex inter-
relationships that exist in target tissue simultaneously 
exposed to chemical and physical oncogens in the envi-
ronment. 
Cancer of the skin is by far the most common type of human 
neoplasm. Of the approximately 1.25 million new cancers di -
agnosed annually in the United States at least 400,000 originate 
in the skin [1] . Epidemiologic studies have clearly shown that 
basal cell and squamous cell carcinomas originate primarily on 
body surfaces that are directly exposed to the environment 
[2,3]. Skin is a major interface between the body a nd its 
environment and is continuously exposed to physical agents 
such as solar radiation , which includes the oncogenic midrange 
UV radiation between 290-320 nm, known as the UVB [2] . It 
is apparent from both animal and human studies that t he 
relationship between UV radiation and skin cancer is not 
simplistic; in the majority of experimental systems employed 
to study carcinogenesis several etio logic factors appear to be at 
work both sequentially and/or simultaneously [2,3] . Thus, it is 
now known that tumor formation in the skin occurs as a result 
of a two-stage process defined as initiation and promotion [4] . 
Some studies on t he mechanism of cancer induction have 
focused primarily on a search for the detection of differences 
in biochemical markers between normal and neoplastic cells or 
for variations in the patterns of enzyme activity in the target 
tissues which might be suitable markers for neoplastic trans-
fo rmation. One such enzyme system is known as the microso-
mal cytochrome P-450 dependent monooxygenase which cata-
lyzes the metabolism of various drugs, chemical carcinogens, 
and other xenobiotics [5] . Of t he cytochrome P-450 dependent 
monooxygenases, aryl hydrocarbon hydroxylase (AHH) has 
been among the most extensively studied marker for neoplastic 
change [6,7]. For example higher inducibility of th is enzyme 
appears to correlate with enhanced risk of tumor susceptibility 
to polycycl ic aromatic hydrocarbons (P AHs) in several inbred 
mouse strains [8) . Other studies have shown that cytochrome 
P-450 dependent xenobiotic metabolizing enzymes are either 
lowered or undetectable in most types of neoplasms [6,9,10]. 
For example, Adamson and Fouts [10] compared the Novikoff 
hepatoma with hepatoma 5123 [11] for their ability to metab-
olize various drugs and concluded that the enzyme activity was 
not detectable in either type of hepatoma. Sultatos and Vessell 
[6] have also shown t hat ethylmorphine N-demethylase and 
aniline hydroxylase activities are lowered in hepatic and mam-
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rna r y carcinomas. On t he other hand Mason and Okey have 
shown t hat t he cytochrome P -450 content is elevated in one 
type of mammary carcinoma [7]. While it i~ well known t_hat 
the skin is directly exposed to both physical and chem1cal 
carcinogens in the environme nt, virtually nothing is known 
about the interaction of these oncogens for skin. 
Cancer of t he skin is readily induced in mice by repeated 
exposure to UVB rad iation whereas virtually nothing is known 
concerning changes in cytochrome P-450 dependent monoox-
ygenases in such animal~ . Recent s~u~ies have reve~ led t? at 
the skin is an important site of xenobJOtiC metabolism mcludmg 
environmental carcinogens such as PAHs (12- 14]. No previous 
study has exam ined carcinogen metabolism in the skin of 
animals with UVB-induced neoplasms. Here we report for the 
first time evidence that prolonged exposure of mouse skin to 
UVB radiation produces major changes in t he basal levels and 
in the inducibili ty of t hese enzymes. 
MATERIALS AND METHODS 
Chemicals 
[3H]benzo(a)pyrene-4,5-oxide (BP-4,5-ox ide) (sp act 289 mCi / mmol) 
nd un labeled BP-4 ,5-oxide were provided by the Cancer Research ~ro!ITam of t he National Cancer Institute, Division of Cancer Cause 
and "prevention (Bethesda, Maryland). [G- ''H]BP (sp act 25 Ci/mmol) 
was purchased from Amersham Searle (Ch icago, Illinois). The radio-
labeled BP-4,5-ox ide and BP were purified by chromatography on 
lumina gel and sil ica gel, respectively, and were greater than 99% 
a ure. Protease (Type XI), m-cresol, nicotinamide aden ine dinucleotide 
phosphate reduced (NADPH) , nicoti namide adenine dinucleotide re-~uced (NADH) , 8- hydroxyqui noline, ribonuclease A (~ype I!l-A) were 
purchased from Sigma Chemical Co. (St. LoUIS, M1ssoun). Phenol 
(greater t han 99% pure), BP and 7-ethoxycoumarin were purchased 
from A ldrich Chemical Co. (Milwaukee, W1sconsm). Tween 20 was 
urc hased from B and B, (Baltimore, Maryland). Standard coal ta r ~olut ion ( USP) was used. All other chemica ls used were of the highest 
purity commercially avai lable. 
Tumor Protocol 
The dorsal skin of groups of randomly selected male SKH-1 hairless 
ice obtained from Temple Univers ity Healt h Sciences, The Skin and ~an;er Hospital, Philadelphia at 8 weeks of age, were radiated using a 
bank of 4 Westinghouse FS-40-T-12 fluorescent su"nlamps. O:: he mice 
ere exposed 3 t imes weekly on alternate days for 2o mm lor 22 weeks :0 UVB (2 .0- 2.2 X 10-• W /cm2 ) at a distance of 9 inches. Control 
nonirradiated an imals were kept in the same room In a sepa rate a rea 
rotected from the light source. Neoplasms developed only on t he ~orsa l s kin beginning afte r 17- 18 weeks of exposure. Gross skin tumors 
appeared after 20- 22 weeks of exposure to UVB light, at wh1ch t1me 
the animals were withdrawn for metabolic studies. 
Treatm.ent of Animals 
For the studies of basal enzyme activity control (non irradiated) , 
non-tumor skin sites and squamous cell ca rcinoma (SC~)-bearing skin 
ofUVB- irradiated mice we re evaluated. E nzyme mduc~JOn was assayed 
after a single topica l application of USP coal tar solu tiOn (1 ml/ 100 g) 
24 h before sacrifice. Non-coal tar t reated animals r ecei:ved t he same 
volume of acetone. For t he dete rmination of the In v1vo bmdmg of BP-
metaboli tes to DNA, animals received a single topical app lication of 1 
nmol [a H) BP (in 100 1'1 acetone) 2 h prior to sacrifice. 7/'1,8c~-D ihyd roxy-
9a,l0 a-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene (BPDE-l)-DNA ad-
duct formation was assessed usi ng enzyme- linked immunosorbent assay 
(ELISA). 
Enzyme Source 
The animals were killed by decapitation. Tissues were removed and 
rinsed thoroughly with ice cold 0.1 M phosphate buffer, pH 7.4. All 
subsequent ope rations were carried out at 0- 4 · c. The sk in was scraped 
with a s harp scalpel blade (Bard-Pa rker No. 20) to remove subcuta-
neous fat a nd muscle. The t issues were minced with cissors in 0.1 M 
phosp hate buffer, pH 7.4, containing 10 mM EDTA. The minced t issue 
was homogeni zed with a Polyt.ron t issue homogenizer (Brinkman In -
struments, Switzerland ) equipped with ST-10 generato r. Microsomes 
were prepared as described previously [1 3],. uspended in homogenizing 
media, and were used as the enzyme source for measuring epox ide 
hydrolase (EH) and monooxygenase activity. Cytosolic fractions were 
used as the enzyme source for measuring glutathione S-transferase 
(GST) activity. 
DNA Extraction and Estimation of Total BP Adducts 
T he DNA from tissue homogenates was extracted essentially as 
described by Kates and Beeson [15] with an addit ional incubation step 
usi ng protease K (0.5 mg/ml). A second extraction was performed using 
Kirby's phenol [1 6] before precipitation with cold 100% ethanol. The 
DNA was t hen digested with ribonuclease A (1000 units/ml) , washed 3 
times with acetone, and dried under a stream of nit rogen. The extracted 
DNA was t hen dissolved in 5.0 ml of 0.1 M sodium chloride, pH 7.0, 
and estimated by measuring its absorption at 260 nm. The purity of 
DNA was assessed by the absorbance ratios 260/280 2: 1.98 and 260/ 
230 2: 2.21 [1 7]. Aliquots were counted on a Packard TriCarb 460 DC 
liquid scint illation spectrometer to determine t he amount of [3H]BP 
metabolites bound to tissue DNA. 
ELISA for BPDE-1-DNA Adducts 
DNA from the skin was prepared as described above and BPDE-1 
adducts quantitated by a competit ive enzyme- linked immunoassay [18, 
19] using a recently developed monoclonal antibody (5Dll) which 
recognizes BPDE-1 modified DNA. Polystyrene U-bottom microplates 
were coated with 5 ng of denatured in vitro modified BPDE-I-DNA 
(0.54 % modified) by evaporation. The hybridoma supernatant was 
diluted (1:2500) and mixed with an equal volume of t he competitor 
before addition to the wells. The competitors consisted of a series of 
known amounts of BPDE-1-DNA from t he in vitro modified sample or 
unknowns. All samples contained 50 pg DNA. After incubation at 37•c 
for 90 min the samples were washed and a conjugate of goat anti mouse 
lgG-alkaline phosphatase was added to each well. Finally the enzyme 
substrate, p -nitrophenyl phosphate was added and color development 
at 405 nm was determined. Under these condit ions t he standard curve 
gave a 50% inhibition of antibody binding to the plate at 20 fmo l of 
BPDE-I-dG adduct. Samples were assayed in triplicate on 2 differen t 
days. 
Enzyme Assays 
AHH activity was determined by a modification of t he method of 
Nebert and Gelboin [20], the details of which have been described 
earlier [ 12,13 J. The quantitation of phenolic BP metabolites was based 
on comparison to fluorescence of a 3-hydroxybenzo(a)pyrene (3-0H-
BP) standard. 7-Ethoxycoumarin 0 -deethylase (ECD) activity was 
determined according to a slight modification of the procedure of 
Green lee and Poland [21] as described previously [12, 13]. EH activity 
in t he microsomal fractions was assayed using radiolabeled BP-4,5-
oxide as substrate according to t he t hin -layer chromatograp hic tech-
nique of Jerina eta! [22], t he details of which were described previously 
[13]. GST activity in cytosol was assayed by t he procedure of Habig et. 
a! [23] using 1-chloro 2,4-dinitrobenzene (CDNB) as a substrate. Cy· 
tochrome P-450 in liver microsomes was measured by t he method of 
Omura and Sato [24] . Protein was determined after precipitation with 
t richloroacetic acid, by the procedure of Lowry et al [25] us ing bovine 
serum albumin as a reference standard. 
RESULTS 
Cutaneous Xenobiotic Metabolism 1:n UVB-Jnduced SCC-
Bearing Mouse Skin 
In Table I a comparison of the basal activit ies of xenobiotic 
metabolizing enzymes in SCC-bearing dorsal skin and in non-
tumor bearing ventral skin of UVB- irradiated mice and in the 
skin of nonirradiated control mice is shown. AHH and ECD 
activities in microsomes prepared from SCC-bearing dorsal 
sk in were 5.6- and 4.8-fold lower t han t hose of the dorsal skin 
of nonirradiated control animals. Non-tumor bearing ventral 
skin of SCC-bearing mice a lso showed 2.2- to 2.3-fold lower 
AHH and ECD enzyme activities as compared to dorsal skin 
of nonirradiated controls. Basal enzyme activ ity as we ll as 
inducibility by topically applied coal tar on cytochrome P-450 
dependent monooxygenases did not differ in dorsa l and ventral 
skin of unirradiated mice (data not shown). Microsomal EH 
activity was simila r in each of the groups. Cytosolic GST 
activity was found to be elevated (173 %) in non-tumor bearing 
ventral skin of UVB- irradi ated SCC-bearing mice as compared 
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to controls but no difference in enzyme activity was observed 
between SCC-bearing skin of the UVB-irradiated animals and 
in the nonirradiated controls. Neither cytochrome P-450 con-
tent nor the enzyme activities were altered in liver of nonirra-
diated contro ls or in UVB-induced SCC-bearing mice (Table 
I) . 
Effect of Topical Application of Coal Tar on Xenobiotic 
Metabolism in UVB-Induced SCC-Bearing Mouse Skin 
Studies of Miyake et al [26] have shown that cytochrome P-
450 monooxygenases in Morris hepatomas are not induced by 
treatment with conventional inducers of cytochrome P -450. 
Other studies have indicated that the drug metabolizing enzyme 
activities of various hepatomas are induced by 3-methylchol-
anthrene and phenobarbital [9]. Our prior studies have shown 
that a coal tar preparation widely used in derma to logic practice, 
is a potent inducer of cutaneous and hepatic cytochrome P-450 
monooxygenases [27] . In the present study we investigated the 
effect of topical application of coal tar on AHH and ECD 
activities in skin and liver of control and UVB-i rradiated SCC-
bearing mice. Table II depicts the inducibility of AHH and 
ECD follow ing topical app lication of coal tar to the tumor-
bearing dorsal skin. Coal tar treatment resulted in a 14-fold 
induction of AHH and ECD activit ies in SCC-bearing dorsal 
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skin of UVB-irradiated mice (Table II). The inducibility of 
these enzymes by coal tar in non-tumor bearing ventral skin of 
UVB-irradiated mice and skin of non-i rradiated controls was 
6- and 3-fold, respectively. It is clear from the results in Table 
II that the inducibility of AHH and ECD following coal tar 
treatment is much higher in SCC-bearing dorsal skin of DYE -
irradiated mice followed by non-tumor bearing ventral skin of 
UVB-irradiated mice and then by nonirradiated control skin. 
The topical application of coal tar also induced hepatic AHH 
and ECD activities but t he extent of inducibility of these 
enzymes in liver of UVB-irradiated SCC-bearing mice and 
nonirradiated controls was similar (6-fold) (Table II). 
Covalent Binding of BP Metabolites to DNA in UVB-induced 
SCC-bearing Mouse Skin 
Table III depicts the in vivo covalent binding of total BP 
metabolites and of BPDE-1 to skin DNA. First t he binding of 
total BP metabo lites to skin DNA was assessed by measurino-
the amount of isotopically labeled BP metabolites bound t~ 
tissue DNA after topica l application of the hydrocarbon. The 
covalent binding of BP metabolites to skin DNA was 2.2-fold 
and 1.9-fold lower in SCC-bearing dorsal skin and non-tumor 
bearing ventral skin ofUVB-irradiated mice, respectively, when 
compared to nonirradiated controls. Interestingly, the binding 
TABLE I. Xehobiotic metabolizing enzyme activities of cutaneous and hepatic tissue of nonirradiated controls and of UVB-irradiated squamous 
cell carcinoma-bearing hairless mice 
AHH activity" ECD activity• 
Dorsal sk in of nonirradiated 10.56 ± 0.12 12.39 ± 0.10 
controls 
Non-tumor bearing ventral skin 4.71 ± 0.091 4.30 ± 0.071 
of UVB-irradiated mice 
SCC-bearing dorsal skin of 1.89 ± 0.04" 2.56 ± 0.04' 
UVB-irradiated mice 
Liver of control non irradiated 625.50 ± 5.63 1198.66 ± 37.82 
mice 
Liver of SCC-bearing UVB-ir- 588.91 ± 14 .32 1166.23 ± 11.44 
radiated mice 
Data represent mean ± SEM of 4 experiments. ND = not detectable. 
o pmol 3-0H BP/min/mg protein. 
b pmol 7-0H EC/min/mg protein. 
' nmol/mg protein. 
d nmol BP-4,5-diol/min/mg protein. 
e nmol CDNB conjugate/min/mg protein. 
'Statistica lly significant from control skin (p < 0.05). 
Cytochrome 
P-450 EH aclivityd 
contentc 
ND 0.11 ± 0.01 
ND 0.11 ± 0.02 
ND 0.09 ± 0.01 
1.21 ± 0.18 2.35 ± 0.18 
1.29 ± 0.06 2.33 ± 0.21 
"Statistically signi!icant from control and non -tumor bearing sk in of UVB-irradiated mice (p < 0.05). 
"Statistically significant from non-tumor bearing sk in of UVB-irradiated mice (p < 0.05). 
GST activity• 
53.83 ± 0.91 
93.14 ± 2.131 
54.8 ± 3.81 h 
1506.24 ± 12.5 
1534.41 ± 11.68 
TABLE II. Effect of coal tar treatment on xenobiotic metabolizing enzyme activities of cutaneous and hepatic tissue of nonirradiated controls and 
of UVB-irradiated squamous cell carcinoma-bearing hairless mice 
AHH activity" ECD activity• 
Dorsal skin of non irrad iated con-
trols 
Non -tumor bearing ventral skin 
of UVB-irradiated mice 
SCC-bearing dorsa l skin of UVB-
irradiated mice 
Liver of control nonirradiated 
mice 
Liver of SCC-bearing UVB- irra-
diated mice 
Data represent mean ± SEM of 4 experiments. 
o pmol 3-0H BP /min/mg protein. 
b pmol 7-0H EC/min/mg protein. 
Control 
9.56 ± 0.11 
3.53 ± 0.08' 
1.63 ± 0.04" 
624.41 ± 6.83 
583.44 ± 7.81 
' Statistically significant fiom control skin (p < 0.05) . 
Coal tar-treated Control 
31.41 ± 0.64 10.48 ± 0.14 
20.28 ± 0.49 ' 3.80 ± 0.10' 
21.84 ± 0.51 2.33 ± 0.04" 
3758.83 ± 30.43 1096.83 ± 20.63 
3674.43 ± 35.81 1008.43 ± 25.12 
"Statistically signi!icant from control and non-tumor bearing skin of UVB-irradiated mice (p < 0.05). 
• Statistically signiiicant from non -tumor bea ring skin of UVB-irradiated mice (p < 0.05). 
Coal tar-treated 
35.41 ± 0.70 
22.06 ± 0.51 ' 
30.67 ± 0.71 '" 
6603.66 ± 58.83 
6389.67 ± 65.21 
June 1985 XENOBIOTIC METABOLISM IN UVB-IRRADIATED SKIN 535 
TABLE III. Effect of coal tar treatment on in uiuo binding of BP 
m£tabolites to cutaneous DNA of control and UVB-irradiated 
squamous cell carcinoma-bearing h01:rless mice 
Control Coal tar-induced 
Tota l BP BPDE-1 Total BP BPDE-1 
metabolite adducts• metabolite adducts 
adducts" adduct.s 
Dorsal skin of nonir- 1.74 0.40 2.81 0.59 
radiated controls 
Non-tumor bearing 
ventral skin of 
0.93 0.24 0.95 0.20 
UVB-irradiaied 
mice 
seC-bearing dorsal 0.80 0.26 1.83 0.57 
skin of UVB-irra-
diated mice 
Data from a typical experiment repeated thrice with identical results. 
a pmol BP metabolites bound/ mg DNA. Estimated by determining 
t he radioactivity bound to DNA. 
b pmol BPDE-1 bound/mg DNA. Estimated by enzyme- linked im-
munoabsorbent assay as described in Materials and Methods. 
of BP metabolites to skin DNA was found to be enhanced 
following topical application of coal tar to nonirradiated control 
animals and to SCC-bearing dorsal skin of UVB-irradiated 
rnice (Table III). The enhancement of binding of BP metabo-
lites to skin DNA evoked by coal tar was higher in SCC-bearing 
dorsal skin of UVB-irradiated mice (2 .3-fold ) whi le that in 
non irradiated control animals was enhanced 1.6-fold. However, 
t he capacity of BP metabolites to bind covalently to skin DNA 
did not increase by coal tar treatment in non-tumor bearing 
ventral skin of UVB-irradiated mice. 
The covalent binding of BPDE-I to skin DNA was then 
evaluated using monoclonal antibodies directed against BPDE-
I modified DNA in an ELISA assay. The covalent binding of 
BPDE-I to skin DNA was found to be appreciably lower in 
seC-bea ring dorsal skin of UVB- irradiated mice (35 %) and in 
non-tumor bearing ventra l skin of UVB-irradiated mice (40%) 
as compared to nonirradiated controls (Table III). The binding 
of BPDE-I to skin DNA was also found to be induced by topical 
application of coal tar to control nonirradiated sk in (48%) and 
to SCC-bearing dorsal skin of UVB-irradiated mice (119 %). 
The binding of BPDE-I to skin DNA was unaffected in non -
tumor bearing skin of the UVB-irradiated mice. 
DISCUSSION 
The effect of chron ic UV irradiation on skin enzymes that 
metabolizes drugs and carcinogens including PAHs was as-
sessed. Prior studies have demonstrated that in several types 
of malignancies cytochrome P-450 dependent xenobiotic me-
tabolizing enzymes are either lowered or nondetectable 
[6,9, 10]. Our findings indicate that basal activities of cyto-
chrome P-450 dependent xenobiotic metabolizing enzymes are 
greatly diminished in the skin of hairless mice chronically 
irradiated with UVB for the induction of cutaneous SCC. It is 
of particular interest that the non-tumor bearing ventral skin 
of the irradiated animals also showed diminished basal AHH 
and ECD activities with va lues intermediate between those in 
non irradiated controls and those in the SCC-bearing dorsal 
skin of the same animals (Table I) . Since the enzyme activities 
in dorsal and ventra l sk in of unirradiated contro ls was similar, 
it is quite possible t hat the lower intensity of response in non-
tumor bearing ventra l skin as compared to dorsal skin of 
irradiated animals is the result of UVB exposure of less inten-
sity. The decrease in cutaneous xenobiotic metabolizing en-
zymes of SCC-bearing skin migh t be due to a loss of, or at least 
a decrease in microsomal enzyme protein which could metab-
olize xenobiotics such as t he PAHs. Since we did not observe 
any change in liver enzyme activities it is unlikely t hat any 
circulating inhibitors or activators stimulated by UVB could 
account for the differences observed in the skin. Adamson and 
Fouts [10] have shown that the loss of mixed function oxidase 
activity in hepatic tumors was due neither to a deficiency of 
cofactors such as NADPH and glucose-6-phosphate nor to the 
presence of inhibitors of xenobiotic metabolizing enzymes. 
LePage and Henderson [28] suggested that the biochemical 
mechanisms of carcinogenesis might best be explored by means 
of the "deletion hypothesis." The deletion theory of carcino(7en-
esis suggests a relationship between the development of ~eo­
plastic cells and the loss of some enzymes found in normal cells 
[29]. This theory could explain the reduction of xenobiotic 
metabolizing enzyme activity in SCC-bearing skin as observed 
in this study. 
. Coal t~r, which is. rich in PAHs, is a known skin carcinogen 
m expenmental ammals and humans and yet is widely em-
ployed therapeutically in dermatologic practice, particularly in 
the treatment of chronic dermatoses such as eczematous der-
matitis and psoriasis [30]. We have previously shown that 
topical application of coal tar to human skin and to neonatal 
rats results in the induction of cutaneous AHH [27,31). The 
data in this study extend these observations and provide evi-
dence for enhanced inducibility of cutaneous AHH and ECD 
by coal tar application in both the SCC-bearing dorsal skin and 
!n t~e non-~umor bearing ventral skin of mice chronically 
Irradiated With UVB. Our results on SCC-bearin(7 skin are 
different than those on mouse hepatomas which showed that 
t he inducibili ty of hepatic monooxygenases by phenobarbital 
and 3-methylcholanthrene was higher in control rather than in 
hepatoma-bearing an imals (9). 
The chronic use of coal tar medications for extended periods 
of time has been associated with the development of skin cancer 
in human populations. Hodgson [32] reported that an individ-
ual treated twice daily for 7 years with applications of a drug 
containing large amounts of coal tar developed cutaneous sec. 
Epidemiologic and occupational studies have clearly shown the 
relationship of chronic skin exposure to coal combustion prod-
ucts to the development of human skin cancer [33]. There is 
evidence to suggest that tumor formation is associated with 
one or more of the several PAHs present in coal tar [34,35) . 
The PAHs require metabolic activation by the cytochrome P-
450-dependent mixed-function oxidase system commonly 
known as AHH [5). The precise relationship between AHH 
activity, inducibility of the enzyme in target tissues, and sus-
ceptibi li ty to chemical carcinogenesis by PAH remains contro-
versial (36,37). It was earlier hypothesized that AHH activity 
is a major determir.ant of t he carcinogenic risk of PAHs [8]. 
More recently it has become clear that the binding of bay-
region diol-epoxides of PAHs to cellular DNA plays a critical 
role in tumor induction by PAHs [38). For example, the tu-
morigenicity of BP appears to involve its metabolism to BPDE-
I and the subsequent binding of this metabolite to DNA [38 
39). ' 
Our data indicate that exposure of the skin of SCC-bearing 
UVB-irradiated mice to coal tar results in greater induction of 
AHH and higher levels of binding of BP metabolites, especially 
BPDE-I to DNA. This suggests that chronically UVB-irradi-
ated skin of these animals may be at higher risk for tumor 
induction by environmental chemicals such as PAHs. This may 
explain the known tendency of human skin cancers to occur 
more frequently in individuals with prior skin malignancies 
[3,40). 
Thanks are due to Ms Sandra Evans for preparing the manuscript 
and to Mr. C. D. Lin for tech nical assistance. 
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